Pharmacology & CKD

American Journal of Nursing

Volumn 105, Issue 9, 2005, Pages 60-72

  Campoy, Sally ^a,b,c,d   Elwell, Rowland ^e  

^a UNIVERSITY OF COLORADO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Pharmacy and Therapeutics Committee   (United States)

^d Chronic Kidney Disease Special Interest Group   (United States)

^e ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY FAILURE; DISEASE COURSE; DRUG EFFECT; DRUG INTERACTION; DRUG MONITORING; DRUG THERAPY; GLOMERULUS FILTRATION RATE; HUMAN; INTESTINE ABSORPTION; METABOLIC CLEARANCE RATE; METABOLISM; NURSING; NURSING ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT; REVIEW; TISSUE DISTRIBUTION;

DISEASE PROGRESSION; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY; GLOMERULAR FILTRATION RATE; HUMANS; INTESTINAL ABSORPTION; KIDNEY FAILURE, CHRONIC; METABOLIC CLEARANCE RATE; NURSING ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; TISSUE DISTRIBUTION;

EID: 25144453417     PISSN: 0002936X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000446-200509000-00029     Document Type: Review

References (33)

1. Excerpts from the United States Renal Data Systems 2002 annual report: atlas of end-stage renal disease in the United States. Am J Kidney Dis 2003;41(4 Suppl 2):v-ix, S7-254.
2. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-266.
3. Grabe DW, et al. Evaluation of drug-related problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997;47(2):117-21.
4. Kaplan B, et al. Chronic hemodialysis patients. Part I: characterization and drug-related problems. Ann Pharmacother 1994;28(3):316-9.
5. Frye RF, Matze GR. Drug therapy individualization for patients with renal insufficiency. In: DiPiro JT, et al., editors. Pharmacotherapy: a pathophysiologic approach. 5th ed. New York: McGraw-Hill; 2002. p. 939-52.
6. Malini PL, et al. Digitalis receptors and digoxin sensitivity in renal failure. Clin Exp Pharmacol Physiol 1985;12(2):115-20.
7. Elston AC, et al. Effect of renal failure on drug metabolism by the liver. Br J Anaesth 1993;71(2):282-90.
8. Snyder RW, Berns JS. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease. Semin Dial 2004;17(5):365-70.
9. Aronoff G, et al., editors. Drug prescribing in renal failure: dosing guidelines for adults. 4th ed. Philadelphia: American College of Physicians; 1999.
10. Kleinbloesem CH, et al. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship. Clin Pharmacol Ther 1985;37(5):563-74.
11. Gupta R, et al. The renal patient with coronary artery disease: current concepts and dilemmas. J Am Coll Cardiol 2004;44(7):1343-53.
12. Paller MS. Drug-induced nephropathies. Med Clin North Am 1990;74(4):909-17.
13. Chobanian AV, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289(19):2560-72.
14. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004;43(5 Suppl 1):S1-290.
15. Suki WN. Use of diuretics in chronic renal failure. Kidney Int Suppl 1997;59:S33-5.
16. Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol 2002;13(3):798-805.
17. Lesho E, et al. Common errors in internal medicine: treating hypertension in patients with elevated serum creatinine. Federal Practitioner 2003;20(9):11-5, 31.
18. Schoolwerth AC, et al. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 2001;104(16):1985-91.
19. Wadworth AN, et al. Atenolol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 1991;42(3):468-510.
20. Holcomb SS. Evaluating chronic kidney disease risk. Nurse Pract 2005;30(4):12-25.
21. Barre P, et al. Efficacy of once-weekly epoetin alfa. Clin Nephrol 2004;62(6):440-8.
22. Toto RD, et al. Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration. Am J Nephrol 2004;24(4):453-60.
23. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(4 Suppl 3):S1-201.
24. Prough DS. Physiologic acid-base and electrolyte changes in acute and chronic renal failure patients. Anesthesiol Clin North America 2000;18(4):809-33.
25. Chertow GM. Prevention of radiocontrast nephropathy: back to basics. JAMA 2004;291(19):2376-7.
26. Merten GJ, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291(19):2328-34.
27. Curhan GC, et al. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 2004;164(14):1519-24.
28. Kurella M, et al. Analgesia in patients with ESRD: a review of available evidence. Am J Kidney Dis 2003;42(2):217-28.
29. Dykeman-Sharpe J. Over-the-counter remedies in chronic renal insufficiency: risks versus benefits. Cannt J 2003;13(2):17-28.
30. Eisenberg DM, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998;280(18):1569-75.
31. Myhre MJ. Herbal remedies, nephropathies and renal disease. Nephrology Nursing Journal 2000;27(5):473-80.
32. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999;47(6):555-67.
33. Loghman-Adham M. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care 2003;9(2):155-71.